← SynDRA
ASARALDEHYDE
SynDRA canonical compound SYN0022521 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- ALDH1A1
- ATAD5
- GNAS
- HDAC6
- KDM4E
- POLI
- PPARD
- SLCO1B1
- SLCO1B3
- TDP1
- THRB
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP19A
- CP1A2
- CP2CJ
- CP2D6
- CP3A7
- ESR1
- ESRRA
- GLI3
- SMAD2
- SMAD3
Cross-references
Synonyms
- 2,4,5-Trimethoxybenzaldehyde
- Asaronaldehyde
- Asarylaldehyde
- Gazarin
- Azarylaldehyde
- 3,4,6-Trimethoxybenzaldehyde
- NCI-C61632
- NDU8J2Q00D
- 2,4,5-trimethoxylbenzaldehyde
- NSC 89299
- DTXCID702217
- TMBZ
- RefChem:82040
- Benzaldehyde, 2,4,5-trimethoxy-
- MFCD00003312
- 2,4,5-Trimethoxy benzaldehyde
- NCGC00091253-05
- SMR000112148
- CCRIS 1296
- HSDB 4502
- EINECS 224-713-3
- UNII-NDU8J2Q00D
- asaronealdehyde
- BRN 1951403
- AI3-36671
- Spectrum_000818
- Asaraldehyde (Standard)
- Spectrum2_000386
- Spectrum3_000170
- Spectrum4_001759
- Spectrum5_000618
- 2,5-Trimethoxybenzaldehyde
- 3,6-Trimethoxybenzaldehyde
- Asaraldehyde (Asaronaldehyde)
- BSPBio_001639
- KBioGR_002238
- KBioSS_001298
Look up ASARALDEHYDE in the interactive SynDRA portal →